ArticleBMC genomic data2025
Complete genome of Leuconostoc mesenteroides B22051 from Panax ginseng Meyer C. A. in South Korea.
Article in BMC genomic data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Characterization and Antibacterial Activity of a Low-Molecular-Weight Bacteriocin-like Inhibitory Substance S-2 Produced byVeterinary sciences · 2026Article
- Complete genome sequence of Leuconostoc lactis B34-1-7-1 isolated from Panax ginseng in South Korea.BMC genomic data · 2026Article
- Complete genome of Leuconostoc mesenteroides B22051 from Panax ginseng Meyer C. A. in South Korea.BMC genomic data · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesLeuconostoc menseteroides is a species of lactic acid bacteria with established safety, frequently isolated from fermented foods such as kimchi, and is Generally Regarded as Safe (GRAS). This species is used as a starter culture for kimchi fermentation in South Korea. In this study, we aimed to evaluate the probiotic potential of Leconostoc menseteroides B22051, isolated from Panax ginseng C. A. Meyer (Ginseng), through genome analysis by assessing probiotic traits including antibiotic resistance, bacteriocin, and redox genes relevant to both human and livestock applications. DATA DESCRIPTION: We isolated a candidate probiotic strain from Panax ginseng Meyer and decoded the complete genome of L. menseteroides B22051. The complete genome was found to be 1,994,797 bp in size with a guanine + cytosine (G + C) content of 37.7%, and is composed of one chromosome (1,943,350 bp) and two plasmids (37,364 bp and 14,083 bp). Genome annotation revealed 71 transfer RNAs, 24 ribosomal RNAs, and 1,987 coding sequences (CDSs). Furthermore, 98.09% and 64.92% of these 1,987 CDSs were assigned to the COG and Gene Ontology classification systems, respectively. Two partial sequences of vanT (32.61% identity) and vanY (34.36% identity) were detected by CARD v3.2.0 analysis, and although in vitro assays confirmed vancomycin resistance, the low sequence identity and absence of a complete van operon indicate that the resistance is intrinsic rather than acquired. An entero_X_chain_beta gene, associated with Enterocin within Bacteriocin Class IIC (chromosomally encoded), along with 28 reductase genes and one oxidase gene identified through Gene Ontology analysis, is present in L. mesenteroides B22051. These genomic findings confirm the probiotic properties of L. menseteroides B22051.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.